Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
MicroRNAs: The Role in Autoimmune Inflammation.
Women's Issues in Multiple Sclerosis.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Dimethylfumarate induces apoptosis in human mast cells.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.

Pages